Extract from the above information

One of the eight essential amino acids for the human body, it combines with ATP to generate S-adenosine, promotes methylation of liver cell membrane phospholipids, reduces intrahepatic bile stasis, strengthens transsulfurization, restores the physiological function of liver cells, promotes the disappearance of jaundice and recovery of liver function, supplies methyl to promote choline synthesis, promotes liver fat metabolism, protects the liver and detoxifies.

It combines with pyrophosphate in the body to form a cocarboxylase, participating in the oxidative decarboxylation reaction of pyruvate and α-ketoglutarate in glucose metabolism, and is necessary for glucose metabolism.

The third generation cephalosporins achieve their bactericidal effect by inhibiting the biosynthesis of the cell wall of sensitive bacteria.

It has an irreversible inhibitory effect on most important β-lactamases produced by strains resistant to β-lactam antibiotics, can protect β-lactam antibiotics from hydrolytic destruction by β-lactamases of resistant bacteria, and has a synergistic effect when used in combination with cefoperazone.

It is a semi-synthetic penicillin antibiotic that has antibacterial effects on piperacillin-sensitive bacteria and beta-lactamase-producing piperacillin-resistant bacteria, including a variety of Gram-negative bacteria, Gram-positive bacteria and anaerobic bacteria.

It is a beta-lactamase inhibitor. Its combination with piperacillin can enhance its antibacterial spectrum and fight against beta-lactamase-producing resistant strains.

This product is a semi-synthetic 14-membered macrolide antibiotic. Its antibacterial spectrum and antibacterial effect are basically similar to those of erythromycin. It is slightly less effective than erythromycin against Gram-positive bacteria, but stronger than erythromycin against Legionella pneumophila. Its antimicrobial effect against Chlamydia pneumoniae, Mycoplasma pneumoniae, and Ureaplasma urealyticum is similar to or slightly stronger than that of erythromycin. This product can penetrate the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the transfer of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis.